Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

Image of text that reads "Breaking News" over lymphoma cells.

First 2025 New Blood Cancer Drug Approval Adds Years of Life for People Living with Mantle Cell Lymphoma

January 17, 2025

An image depicting tablets and laptops with text that reads news

Resources for Blood Cancer Patients and Families Affected by the California Wildfires

January 17, 2025

An image depicting tablets and laptops with text that reads news

The Leukemia & Lymphoma Society Names Lore Gruenbaum, Ph.D., New Chief Scientific Officer

January 14, 2025

Image of text that reads "Breaking News" over blood cancer cells.

FDA Approves New Drug to Treat a Serious Immune Condition that Can Affect Children with Blood Cancer

January 3, 2025

Sunbelt Rentals Announces Partnership with The Leukemia & Lymphoma Society to Help Blood Cancer Patients and Their Families

December 12, 2024

From left to right: Dr. Lee Greenberger, LLS Chief Scientific Officer; LLS Excellence in Scientific Service award winners, Dr. Jonathan Licht and Dr. Susan O’Brien.

The Leukemia & Lymphoma Society Honors 6 Scientists for their Contributions to Blood Cancer Research at Event During American Society of Hematology Annual Meeting

December 9, 2024

Image of text that reads "Breaking News" over leukemia cells.

FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia

December 6, 2024

Image of text that reads "Breaking News" over blood cancer cells.

New Formulation of Important CML Drug Comes with No Mealtime Restrictions

December 6, 2024

Image of text that reads "Breaking News" over blood cancer cells.

Oral Formulation of Methotrexate Now Available for Children with Leukemia Subtype

December 6, 2024

Media Requests

For all media-related inquiries and interview requests please email mediarelations@lls.org. An LLS representative will respond as soon as possible.

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.

Alternative Proxies:

Alternative Proxy